Sectoral Asset Management Inc 4 D Molecular Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $1.39 Million - $3.03 Million	142,510 New	142,510 $2.89 Million
Q1 2023 May 12, 2023	BUY	$15.45 - $23.19 $404,681 - $607,415	26,193 Added 48.65%	80,029 $1.38 Million
Q4 2022 Feb 10, 2023	BUY	$6.85 - $25.46 $368,776 - $1.37 Million	53,836 New	53,836 $1.2 Million
Q1 2021 May 14, 2021	SELL	$35.94 - $52.67 $187,750 - $275,148	-5,224 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$38.43 - $47.36 $200,758 - $247,408	5,224 New	5,224 $217,000

150

56.3M

55.6K

167K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $337M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.